Godavari Biorefineries Limited (GODAVARIB)
Press Release for the Quarter ended June 30, 2026
Press Release - Q1FY27
- Total Income Rs. 559.9 Cr +4.8% y-y; EBITDA Rs. 2.6 Cr; PAT Rs. -19.3 Cr
- Bio-based Chemicals segment showed strong revenue growth and margin expansion in Q1 FY27
- Commissioned 200 KLPD grain-based distillery, total ethanol capacity increased to 800 KLPD
- Filed Indian patent for branched alcohols manufacturing process
- CDSCO application filed for preliminary efficacy trials of novel anti-cancer molecule, trials expected Q3 FY27
- CMD: Focus on expanding bio-based chemicals, strategic partnerships, and innovation commercialization
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 GODAVARIB — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add GODAVARIB to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Godavari Biorefineries Limited
Important.
The summary above is generated automatically from Godavari Biorefineries Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.